×
Friday, April 10, 2026

Cue Health rode Covid to a $3 billion valuation. Now it faces a rocky future - STAT

t didn’t have the brand recognition of Abbott, or the billions of the medical technology multinational Becton Dickinson. Before the pandemic hit, Cue Health didn’t even have a product on the market. What the fledgling company did have in July 2020 was a deal to provide its newly authorized Covid-19 test for the National Basketball Association’s highly publicized bubble.



Read Full Story: https://www.statnews.com/2022/06/27/cue-health-covid-test-stock-investigation/